Our Work
Latham Advises on Financing for Frazier Healthcare Partners’ Completed Acquisition of BioMatrix
July 1, 2024
Multidisciplinary team represents the private credit lenders supporting the private equity firm’s acquisition of the home infusion services provider.
Frazier Healthcare Partners, a Seattle-based, healthcare-focused investment firm, has announced that it has completed its acquisition of BioMatrix Holdings, LLC, a leading specialty infusion pharmacy.
Latham & Watkins LLP represented the private credit lenders in the transaction with a team led by New York partners Stelios Saffos and Peter Sluka, Chicago partner John Lister, Los Angeles partners Jason Bosworth and Jeff Senac, and Houston counsel Bryce Kaufman, with associate Sean Travers. Advice was also provided on tax matters by New York partner Bora Bozkurt, with associate Sam Yang; on healthcare regulatory matters by Washington, D.C. counsel Nicole Liffrig Molife; and on employee benefits matters by Chicago partner Ben Rosemergy.